Page 203 - Aet News Today

The funding round was led by 8VC and included participation from Chelsea Clinton’s fund, Metrodora; the Female Founders Fund; Collaborative Fund; and Alumni Ventures. In total, Oula has raised $22.3 million. The company plans to use the funds to grow in its New York market and add more services.

There's been a recent wave of nurse strikes, but Theresa Brown — a nurse and New York Times bestselling author — said she's never met a nurse who happily embraces striking. Nurses only strike when it's the only option left to protect patients and deliver quality care, she declared.

The FDA approved a change in Rybelsus’s label, allowing the drug to be used as an initial therapy for type 2 diabetes patients. The once-daily pill has already become a blockbuster product for Novo Nordisk.

Dr. B began as a virtual service providing access to Covid-19 vaccines and later Covid-19 treatments. It has now expanded to treatments for dermatology, sexual health, reproductive health and primary care.

UC Davis Health announced the first startup to come out of its health tech innovation incubator. The company, named WellCent, is a platform that allows patients and caregivers to onboard medical devices into their home and access digital health resources.

In a media briefing during the J.P. Morgan Healthcare Conference in San Francisco, Paul Hudson said unlike Sanofi, large pharma companies with top-selling drugs have a portfolio akin to a leaky bathtub because in a few years, they will have to replace much of that revenue as drug patents expire.

M&A activity among health systems picked up last year — key trends included cross-market mega-mergers and academic medical centers expanding their community hospital networks. Despite tough economic conditions, Kaufman Hall experts expect this activity to continue growing in 2023.

Microsoft is making a strategic investment in Paige, which is leveraging AI for cancer diagnostics and treatment. Paige will also use Microsoft Azure as its cloud provider for the Paige Platform.

Xofluza, a flu antiviral drug developed by Roche and Shionogi, is now approved in Europe for children age 1 and older. The European Commission decision expands the patient population for the drug, which was previously approved for treating adolescents and adults.

LeanTaaS acquired healthcare automation company Hospital IQ. The two companies made the deal because their products complement each other — Hospital IQ provides staff optimization solutions, while LeanTaaS makes software to optimize capacity for operating rooms, infusion centers and inpatient beds.